XML 33 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
Schedule of Impact of Restatement on Financial Statements The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below.
 
    
As of December 31, 2020
 
    
As Previously
Reported
   
Restatement
Adjustment
   
As Restated
 
Balance Sheet
      
Total assets
   $ 404,063,677     $ —       $ 404,063,677  
  
 
 
   
 
 
   
 
 
 
Liabilities and stockholders’ equity
      
Total current liabilities
   $ 320,025     $ —       $ 320,025  
Deferred legal fees
     100,000       —         100,000  
Deferred underwriting commissions
     14,087,500       —         14,087,500  
Derivative liabilities
     —         49,674,170       49,674,170  
  
 
 
   
 
 
   
 
 
 
Total liabilities
     14,507,525       49,674,170       64,181,695  
Class A common stock, $0.0001 par value; shares subject to possible redemption
     384,556,150       (49,674,170     334,881,980  
Stockholders’ equity
      
Preferred stock - $0.0001 par value
     —         —         —    
Class A common stock - $0.0001 par value
     179       497       676  
Class B common stock - $0.0001 par value
     1,006       —         1,006  
Additional
paid-in-capital
     5,215,685       25,163,513       30,379,198  
Accumulated deficit
     (216,868     (25,164,010     (25,380,878
  
 
 
   
 
 
   
 
 
 
Total stockholders’ equity
     5,000,002       —         5,000,002  
Total liabilities and stockholders’ equity
   $ 404,063,677     $ —       $ 404,063,677  
  
 
 
   
 
 
   
 
 
 
    
Period From August 31, 2020 (Inception)

Through December 31, 2020
 
    
As Previously
Reported
   
Restatement
Adjustment
   
As Restated
 
Statement of Operations
      
Loss from operations
   $ (290,641   $ —       $ (290,641
Other (expense) income:
      
Change in fair value of derivative liabilities
     —         (24,193,170     (24,193,170
Financing costs - derivative liabilities
     —         (970,840     (970,840
Net gain from investments held in Trust Account
     78,522       —         78,522  
  
 
 
   
 
 
   
 
 
 
Total other (expense) income
     78,522       (25,164,010     (25,085,488
  
 
 
   
 
 
   
 
 
 
Loss before income tax expense
     (212,119     (25,164,010     (25,376,129
Income tax expense
     4,749       —         4,749  
Net loss
   $ (216,868   $ (25,164,010   $ (25,380,878
  
 
 
   
 
 
   
 
 
 
Basic and Diluted weighted-average Class A common shares subject to possible redemption outstanding
     38,473,726       (2,582,662     35,891,064  
  
 
 
   
 
 
   
 
 
 
Basic and Diluted net loss per Class A common shares subject to possible redemption
   $ —       $ —       $ —    
  
 
 
   
 
 
   
 
 
 
Basic and Diluted weighted-average
non-redeemable
Class A and Class B common shares outstanding
     10,646,616       1,585,845       12,232,461  
  
 
 
   
 
 
   
 
 
 
Basic and Diluted net loss per
non-redeemable
Class A and Class B common shares
   $ (0.02   $ 2.10     $ (2.08
  
 
 
   
 
 
   
 
 
 
 
    
Period From August 31, 2020 (Inception) Through

December 31, 2020
 
    
As Previously

Reported
   
Restatement

Adjustment
    
As Restated
 
Statement of Cash Flows
       
Net cash used in operating activities
     (491,670     —          (491,670
Net cash used in investing activities
     (402,500,000     —          (402,500,000
Net cash provided by financing activities
     404,071,303          404,071,303  
  
 
 
   
 
 
    
 
 
 
Net change in cash
   $ 1,079,633     $ —        $ 1,079,633